The Manufacturers Life Insurance Company bought a new stake in shares of Arcosa, Inc. (NYSE:ACA – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 213,057 shares of the company’s stock, valued at approximately $30,955,000. The Manufacturers Life Insurance Company owned 0.43% of Arcosa at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in ACA. State of Wyoming purchased a new stake in Arcosa in the 1st quarter valued at about $30,000. GHP Investment Advisors Inc. bought a new stake in shares of Arcosa during the first quarter valued at approximately $32,000. Farther Finance Advisors LLC boosted its holdings in shares of Arcosa by 73.4% in the fourth quarter. Farther Finance Advisors LLC now owns 307 shares of the company’s stock valued at $33,000 after purchasing an additional 130 shares during the period. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Arcosa in the second quarter valued at approximately $53,000. Finally, Allworth Financial LP grew its stake in Arcosa by 392.5% in the fourth quarter. Allworth Financial LP now owns 394 shares of the company’s stock worth $42,000 after purchasing an additional 314 shares in the last quarter. Hedge funds and other institutional investors own 90.66% of the company’s stock.
Arcosa Stock Performance
ACA stock opened at $145.51 on Friday. The firm has a market cap of $7.15 billion, a price-to-earnings ratio of 14.58, a PEG ratio of 2.18 and a beta of 1.05. The firm has a 50-day simple moving average of $144.88 and a two-hundred day simple moving average of $127.68. Arcosa, Inc. has a one year low of $89.03 and a one year high of $146.92. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.31 and a current ratio of 3.12.
Wall Street Analyst Weigh In
ACA has been the subject of a number of research analyst reports. Texas Capital lowered Arcosa from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 23rd. Wall Street Zen upgraded shares of Arcosa from a “sell” rating to a “hold” rating in a report on Saturday, May 30th. Barclays raised their target price on shares of Arcosa from $115.00 to $140.00 and gave the company an “overweight” rating in a research report on Monday, May 4th. Stephens set a $150.00 price target on shares of Arcosa in a research report on Thursday, August 6th. Finally, Oppenheimer lowered shares of Arcosa from an “outperform” rating to a “market perform” rating in a report on Friday, June 26th. Three investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $141.25.
Check Out Our Latest Analysis on Arcosa
Arcosa Company Profile
Arcosa, Inc (NYSE: ACA) is a Dallas‐based industrial company that was formed through the spin‐off of Trinity Industries’ construction products business in 2018. Since its inception, Arcosa has focused on the manufacture and sale of critical infrastructure components, serving a diverse set of end markets including transportation, construction and energy.
The company’s Construction Products segment produces a broad range of highway safety products, such as guardrail systems, sign supports and crash cushions, as well as aggregates and ready‐mix concrete.
Further Reading
- Five stocks we like better than Arcosa
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA – Free Report).
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.
